In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 621-626

  Sjostrom J E ^a   Fryklund, J ^a   Kuhler T ^a   Larsson, H ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

H 215 69; H 223 43; H 243 75; H 260 54; LANSOPRAZOLE; MERCAPTOETHANOL; OMEPRAZOLE; OMEPRAZOLE DERIVATIVE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; SCAVENGER; SULFENAMIDE DERIVATIVE; TRITIUM; UNCLASSIFIED DRUG;

ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CONTROLLED STUDY; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; FETAL CALF SERUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HELICOBACTER PYLORI; INCUBATION TIME; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; PRIORITY JOURNAL;

EID: 0029918613     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.621     Document Type: Article

References (26)

1. Bayerdoerffer, E., G. A. Mannes, A. Sommer, W. Hoechter, J. Weingart, R. Hats, N. Lehn, G. Ruckdesehel, P. Dirschedl, and M. Stolte. 1992. High dose omeprazole treatment combined with amoxicillin eradicates Helicobacter pylori Eur. J. Gastroenterol Hepatol. 4:697-702.
2. Bayless, A. V., and O. E. Millner. Jan. 1980 U.S. patent 4,182,881.
3. Belli, W. A., and J. Fryklund. 1995. Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori using permeabilized cells. Antimicrob. Agents Chemother. 39:1717-1720
4. Biasco, G., M. Miglioli, L. Barbara, R. Corinaldesi. and G. D. Febo. 1989. Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet ii: 1403.
5. Borg, K. O., and L. Olbe. 1985. Omeprazole - a survey of preclical data. Scand. J. Gastroenterol 20(Suppl. 108):1-20.
6. Brändström, A., P. Lindberg, N.-Å. Bergman, T. Alminger, K. Ankner, U. Junggren, B. Lamm, P. Nordberg, M. Erickson, I. Grundevik, I. Hagin, K.-J. Hoffmann, S. Johansson, S. Larsson, I. Löfberg, K. Ohlson, B. Persson, I. Skånberg, and L. Tekenbergs-Hjelte. 1989. Chemical reactions of omeprazole and omeprazole analogues. Acta Chem. Scand 43:536-611.
7. Eaton, K. A., C. L. Brooks, D. R. Morgan, and S. Krakowka. 1991. Essential role of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotie piglets. Infect Immun. 59:2470-2475.
8. +-ATPasc Nature (London) 290:159-161.
9. Ferrero, R. L., V. Cussac, P. Courcoux, and A. Labigne. 1992. Construction of isogenic urease-negative mutants of Helicobacterpylon by allelic exchange. J. Bacteriol. 174:4212-4217.
10. Ferrero, R. L., and A. Lee. 1991. The importance of urease in acid protection for the gastric-colonising bacteria Helicobacter and Helicobacter felis sp. nov Microb. Ecol. Health Dis. 4:121-134.
11. +-ATPase by omeprazole. Biochem. Pharmacol. 37:2543-2549.
12. Fujiyama, K., T. Fujioka, R. Kodama, T. Kubota, K. Murakami, and M. Nasu. 1993. The in vitro activities of various proton pump inhibitors against Helicobacter pylori. Acta Gastroenterol. Belg. 56:135.
13. Glupezynski, Y. 1993 In vitro susceptibility testing of Helicobacter pylon to antimicrobial agents: basis for treatment of microbiologists' obsession? Zentralbl. Bakteriol. Parasitenkd. Infektionskr. Hyg. Abt. 1 Orig. 280:227-238.
14. Hunt, R. H. 1993. H.p. and pH: implications for the eradication of Helicobacter pylori. Scand. J. Gastroenterol. 28:12-16
15. Iwahi, T., H. Satoh, M. Nakao, T. Iwasaki, T. Yamazuki, K. Kubo, T. Tamura, and A. Imada. 1991. Lansoprazole. a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori Antimicrob. Agents Chemother. 35:490-496.
16. Kühler, T., J. Fryklund, N.-Å. Bergman, J. Weilitz, A. Lee, and H. Larsson. 1995. Structure-activity relationship of omeprazole and analogues as Helicobacter pylon urease inhibitors. J. Med Chem. 38:4906-4916.
17. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature (London) 227:680-685.
18. Larsson, H., J. Fryklund, T. Kühler, J. O'Rourke, and A. Lee. 1993. Omeprazole has no antibacterial effect in vivo in the Helicobacter felis infected rat. Acta Gastroenterol. Belg. 56:140.
19. Logan, R. P. H., P. A. Gummett, B. T. Hegarty, M. M. Walker, J. H. Baron, and J. J. Misiewicz. 1992 Clarithromycin and omeprazole for Helicobacter pylori. Lancet 340:239.
20. Mainguet, P., M. Delmee, and J. C. Debongnic. 1989. Omeprazole, Campylobacter pylori, and duodenal ulcer Lancet ii:389-390.
21. Mauch, F., G. Bode, and P. Malfertheiner. 1993. Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors. Am. J. Gastroenterol. 88:1801-1802
22. Nagata, K., H. Satoh, T. Iwahi, T. Shimoyama, and T. Tamura. 1993. Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylon: unique action selective for H. pylori cells Antimicrob. Agents Chemother. 37:769-774.
23. Schade, C., G. Flemström, and L. Holm. 1994. Hydrogen ion concentration in the mucus layer on top of acid-stimulated and -inhibited rat gastric mucosa Gastroenterology. 107:180-188.
24. Sjöström, J. E., and H. Larsson. Factors affecting growth and antibiotic susceptibility of Helicobacter pylori; effect of pH and urea on survival of wild-type and a urease-deficient mutant. J. Med. Microbiol., in press.
25. Suerbaum, S., H. Leying, K. Klem, and W. Opferkuch. 1991. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur. J. Clin. Microbioi. Infect. Dis. 10:92-93.
26. Unge, P., A. Gad, H. Gnarpe, and J. Olsson. 1989. Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylon in patients with antral gastritis? A pilot study. Scand. J. Gastroenterol. 24(Suppl. 167):49-54.